The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy

BACKGROUND: Glucocorticoid therapy is the most common cause of iatrogenic osteoporosis. Less is known regarding the effect of glucocorticoids when used as replacement therapy on bone remodelling in patients with adrenal insufficiency. Enhanced intracellular conversion of inactive cortisone to active...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Endocr Disord
Egile Nagusiak: Dineen, Rosemary, Behan, Lucy-Ann, Kelleher, Grainne, Hannon, Mark J., Brady, Jennifer J., Rogers, Bairbre, Keevil, Brian G., Tormey, William, Smith, Diarmuid, Thompson, Christopher J., McKenna, Malachi J., Arlt, Wiebke, Stewart, Paul M., Agha, Amar, Sherlock, Mark
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7547490/
https://ncbi.nlm.nih.gov/pubmed/33036588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-020-00633-1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak